Other News

CARMAT: Continuing Progress in Line with the Objective of Obtaining CE Marking in 2019

PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced an update on the progress of the PIVOTAL study and the latest developments regarding […]

Abiomed (ABMD) Reports European Approval (CE Marking) for Impella 5.5 & 1st Patient Treated at University Heart Center Hamburg

Abiomed, Inc. (NASDAQ: ABMD) announced today that the Impella 5.5™ heart pump received CE marking1 approval in Europe and the first patient was treated at University Heart Center in Hamburg, Germany. The Impella 5.5 heart pump further enhances Abiomed’s product portfolio and provides physicians a 30-day, ambulatory, wean-able, forward flow heart pump. […]

Paragonix Technologies, Inc. Announces Presentation of the SherpaPak™ Cardiac Transport Systems and SherpaPerfusion™ Cardiac Transport System at the 38th Annual Meeting of the International Society for Heart and Lung Transplantation

BRAINTREE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. will present the SherpaPak™ Organ Transport product line at Booth 14 during the 38th Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT) (Nice, France, 11-14 April 2018). The SherpaPak™ Organ Transport product line1,2 combines innovative cooling technology with safe, consistent methods for cold […]

Transradial Access Market 2018 – Global Forecast 2022: Becton, Dickinson and Company (US) and Terumo Dominated the Market in 2017 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) – Global Forecast 2022” report has been added to ResearchAndMarkets.com’s offering. The Global Transradial Access Devices Market is Expected to Grow at a CAGR of 7.5% […]

Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes

LAKE OSWEGO, Ore. and SILVER SPRING, Md., April 3, 2018 /PRNewswire/ — BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States. BioEnvelope will be available from BIOTRONIK starting in April 2018. BioEnvelope reduces scar formation and has been shown to mitigate the […]

The global inferior vena cava (IVC) filters market is forecasted to grow at a CAGR of 11.24% during the period 2018-2022

NEW YORK, April 3, 2018 /PRNewswire/ — About Inferior Vena Cava (IVC) Filters The IVCF is a type of vascular filter that is inserted into the inferior vena cava to prevent blood clots from moving from the veins in the legs and pelvis to the lung, which can lead to life-threatening pulmonary embolism […]

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

MARLBOROUGH, Mass., April 3, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Securus Medical Group, Inc., a privately-held company that has developed a thermal monitoring system for the continuous measurement of esophageal temperature. Boston Scientific has been an investor in Securus since 2016, and the […]

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

FLAGSTAFF, Ariz., April 3, 2018 /PRNewswire/ — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already […]

CorWave is Set to Receive about $3.5 Million in Financing Through France’s Worldwide Innovation Challenge for Its NovaPulse Program, a Mini-Invasive Solution for Cardiac Support

CLICHY, France–(BUSINESS WIRE) CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it has been awarded almost $3.5 million in financing for its R&D program NovaPulse in the Silver Economy category. This is part of phase 2 of […]

IVC Filter Lawsuit News: C.R. Bard Ordered to Pay $3.6 Million at Conclusion of First Federal Bellwether Trial, Bernstein Liebhard LLP Reports

NEW YORK, April 2, 2018 /PRNewswire/ — C.R. Bard, Inc. has been ordered to pay $3.6 million to a Georgia woman who suffered serious complications after the company’s G2 inferior vena cava (IVC) filter fractured inside her body. The case was the first to go to trial in the U.S. District Court, District of Arizona, where more than […]